Company intelligence / Profile preview

Molecular Warehouse

Guildford, England, United Kingdomzoominfo.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Molecular Warehouse developed a patented, mobile-enabled diagnostic platform leveraging synthetic biology to create universal biosensors, allowing users to perform molecular diagnostic tests on smartphones. Their technology enabled rapid, economical, and accurate health monitoring outside traditional clinical settings. The company reengineered enzymes like glucose dehydrogenase for broader diagnostic applications.

Therapeutic areas: Other
Modalities: ProteinRecombinant proteinSynthetic biology-based biosensor technology
Industry: Metabolite Diagnostics

Partnerships

Oxford Technology Management (investor/partner)MassChallenge (accelerator/investor)

Beyond the preview

Go deeper on Molecular Warehouse.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molecular Warehouse.

Explore the full profile